Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4641]

Tivozanib licensed in EU for first-line treatment of advanced renal cell carcinoma

Tivozanib licensed in EU for first-line treatment of advanced renal cell carcinoma

Fulvestrant receives FDA approval as monotherapy for expanded use in HR/HER2- breast cancer

Fulvestrant receives FDA approval as monotherapy for expanded use in HR/HER2- breast cancer

Boosting immune cell memory to improve vaccines and cancer immunotherapy

Boosting immune cell memory to improve vaccines and cancer immunotherapy

First response of central nervous system tumour to CAR T-cells reported

First response of central nervous system tumour to CAR T-cells reported

Most melanomas don't arise from existing moles

Most melanomas don't arise from existing moles

Concurrent treatment with OX40 and PD1-targeted cancer immunotherapies may be detrimental

Concurrent treatment with OX40 and PD1-targeted cancer immunotherapies may be detrimental

HPV vaccination rates lag for vulnerable population of childhood cancer survivors

HPV vaccination rates lag for vulnerable population of childhood cancer survivors

Researchers discover cancer stem cell pathway in endometrial cancer

Researchers discover cancer stem cell pathway in endometrial cancer

Scientists develop novel 'dot' system to improve cancer detection

Scientists develop novel 'dot' system to improve cancer detection

Artificial intelligence helps with earlier detection of skin cancer

Artificial intelligence helps with earlier detection of skin cancer

More from ecancer